Fancl (4921) Q2 2025 earnings summary

Executive summary

• Net sales for the interim period decreased 3.5% year-over-year to ¥52,199 million, with declines in both core cosmetics and nutritional supplements businesses.

• Operating income dropped 21.7% to ¥4,742 million, and net income attributable to owners fell 40.9% to ¥2,550 million, impacted by lower sales and extraordinary losses related to a tender offer.

• The company is undergoing a major ownership change, with Kirin Holdings acquiring a 75.24% stake via a tender offer, leading to planned delisting and share consolidation.

Financial highlights

• Gross profit declined to ¥35,401 million from ¥36,644 million year-over-year.

• Ordinary income decreased 23.3% to ¥4,878 million.

• Comprehensive income dropped 39.8% to ¥2,609 million.

• Cash and cash equivalents at period end were ¥33,816 million, down ¥8,264 million from the previous fiscal year end.

Outlook and guidance

• No full-year earnings forecast disclosed due to the planned delisting following the tender offer by Kirin Holdings.